/ CompletedNot Applicable A randomized, Open-label, Single Dose, Two Treatment, Three-Period, Three-Sequence, Partial Replicate, Crossover, Multicentre, Bioequivalence Study of Capecitabine 500 mg Tablets (Manufactured by SP Accure Labs Pvt. Ltd., India) with Xeloda® (Capecitabine 500 mg Tablets Distributed Roche Registration GmbH) in Adult Cancer Patients Under Fed Condition.
100 Clinical Results associated with SP Accure Labs Pvt Ltd.
0 Patents (Medical) associated with SP Accure Labs Pvt Ltd.
100 Deals associated with SP Accure Labs Pvt Ltd.
100 Translational Medicine associated with SP Accure Labs Pvt Ltd.